1. Home
  2. TLF vs NEUP Comparison

TLF vs NEUP Comparison

Compare TLF & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tandy Leather Factory Inc.

TLF

Tandy Leather Factory Inc.

N/A

Current Price

$2.64

Market Cap

19.5M

ML Signal

N/A

Logo Neuphoria Therapeutics Inc.

NEUP

Neuphoria Therapeutics Inc.

HOLD

Current Price

$3.94

Market Cap

20.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLF
NEUP
Founded
1980
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
20.6M
IPO Year
2006
2002

Fundamental Metrics

Financial Performance
Metric
TLF
NEUP
Price
$2.64
$3.94
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$21.00
AVG Volume (30 Days)
24.6K
197.7K
Earning Date
05-11-2026
05-23-2026
Dividend Yield
32.05%
N/A
EPS Growth
1122.22
N/A
EPS
0.08
N/A
Revenue
$76,324,000.00
$15,649,448.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.38
N/A
Revenue Growth
2.60
N/A
52 Week Low
$2.20
$3.19
52 Week High
$3.36
$21.31

Technical Indicators

Market Signals
Indicator
TLF
NEUP
Relative Strength Index (RSI) 69.55 54.18
Support Level $2.27 $3.75
Resistance Level $2.75 $4.15
Average True Range (ATR) 0.09 0.17
MACD 0.02 0.03
Stochastic Oscillator 66.27 33.90

Price Performance

Historical Comparison
TLF
NEUP

About TLF Tandy Leather Factory Inc.

Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, and Canada. it generates the highest revenue from the United States.

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

Share on Social Networks: